Cognitive Behavioral Therapy for Depression in Parkinson's Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00810628|
Recruitment Status : Terminated
First Posted : December 18, 2008
Last Update Posted : October 24, 2014
The purpose of this pilot program is to develop and evaluate a new treatment program for depression in Parkinson's disease (PD). The treatment uses Cognitive Behavior Therapy(CBT)to teach patients how to become more aware of their thoughts and feelings and to change thinking patterns and behaviors that may be related to depressive symptoms. This is the first time that this treatment has been used in a group setting for depression in PD.
Target population is patients in the Movement Disorders Clinic at Oregon Health & Science University who have Parkinson's disease and mild to moderate depression.
|Condition or disease||Intervention/treatment||Phase|
|Parkinson's Disease Depression||Behavioral: Cognitive Behavioral Therapy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||12 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Depression in Parkinson's Disease: A Pilot Project Using Cognitive Behavioral Therapy (CBT) to Improve Depression and Coping|
|Study Start Date :||January 2009|
|Actual Primary Completion Date :||September 2009|
|Actual Study Completion Date :||December 2009|
All subjects in same investigative group with same CBT intervention.
Behavioral: Cognitive Behavioral Therapy
Individual interviews and group discussion/training.
- The change in CESD score [ Time Frame: Baseline and 10 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00810628
|United States, Oregon|
|Oregon Health & Science University|
|Portland, Oregon, United States, 97239|
|Principal Investigator:||Julie H. Carter, MS||Oregon Health and Science University|
|Principal Investigator:||Kristine Hanna, PhD||Oregon Health and Science University|